PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25670957-3	2015	Despite of the theoretical relevancy, the antidepressant effect of bupropion in IFN-alpha-induced depression has never been studied.	Bupropion	67-76	interferon alpha 1	Homo sapiens	80-89	
25670957-7	2015	This preliminary open-label study suggests that bupropion is effective in treating IFN-alpha-induced depressive and somatic symptoms.	Bupropion	48-57	interferon alpha 1	Homo sapiens	83-92	
15150377-0	2004	Bupropion for treatment of interferon-induced depression.	Bupropion	0-9	interferon alpha 1	Homo sapiens	27-37	
15150377-1	2004	OBJECTIVE: To report the effect of bupropion in a patient with interferon (IFN)-induced depression and review the use of antidepressants for treatment of depressive symptoms associated with IFN therapy.	Bupropion	35-44	interferon alpha 1	Homo sapiens	63-73	
15150377-1	2004	OBJECTIVE: To report the effect of bupropion in a patient with interferon (IFN)-induced depression and review the use of antidepressants for treatment of depressive symptoms associated with IFN therapy.	Bupropion	35-44	interferon alpha 1	Homo sapiens	75-78	
15150377-1	2004	OBJECTIVE: To report the effect of bupropion in a patient with interferon (IFN)-induced depression and review the use of antidepressants for treatment of depressive symptoms associated with IFN therapy.	Bupropion	35-44	interferon alpha 1	Homo sapiens	190-193	
15150377-2	2004	CASE SUMMARY: A 43-year-old white woman with chronic hepatitis C and severe IFN-induced depression was treated with sustained-release bupropion initiated at 150 mg/day for 7 days and 100 mg twice daily thereafter.	Bupropion	134-143	interferon alpha 1	Homo sapiens	76-79	
15150377-8	2004	CONCLUSIONS: Sustained-release bupropion might be of potential benefit in patients with interferon-induced depression.	Bupropion	31-40	interferon alpha 1	Homo sapiens	88-98